R. Robles

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

J. Leonard, K. Kolibaba, J. Reeves, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

Dinh Q. Phung, C. A. Shaw, M. Kumar, 2021, The Lancet Oncology.

Safety of bevacizumab (BV) among patients (pts) receiving first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): Preliminary results from a larger registry in the U.S

R. Robles, A. Grothey, F. Kabbinavar, 2005 .

A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other solid tumors.

R. Robles, J. Infante, M. Tortorici, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS.

R. Robles, M. Jacobson, L. Gee, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Renal Amyloidosis in a Patient with X-linked Agammaglobulinemia (Bruton’s Disease) and Bronchiectasis

R. Robles, M. Gonzalo-Garijo, R. Pérez-Calderón, 2013, Journal of Clinical Immunology.

Axitinib (AG-013736) in combination with FOLFOX and bevacizumab (Bev) in patients (pts) with metastatic solid tumors: A phase I study

R. Robles, M. Tortorici, B. Hee, 2008 .

Randomized Phase 2 Open-Label Study of R-CHOP ± Bortezomib in Patients (Pts) With Untreated Non-Germinal Center B-Cell-like (Non-GCB) Subtype Diffuse Large Cell Lymphoma (DLBCL): Results From the Pyramid Trial (NCT00931918).

J. Leonard, K. Kolibaba, J. Reeves, 2015, Clinical advances in hematology & oncology : H&O.

Preliminary safety and effectiveness of bevacizumab (BV) based treatment in subpopulations of patients (pts) with non-small cell lung cancer (NSCLC) from the ARIES study: A bevacizumab (BV) treatment observational cohort study (OCS).

R. Robles, T. Lynch, D. Spigel, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Renal Amyloidosis in a Patient with X-linked Agammaglobulinemia (Bruton’s Disease) and Bronchiectasis

R. Robles, M. Gonzalo-Garijo, R. Pérez-Calderón, 2013, Journal of Clinical Immunology.